CVR Medical Corp. (CRRVF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | - USD | 100.0% |
| 2021 | -685.28 Thousand USD | -582.3% |
| 2020 | -43.48 Thousand USD | 98.25% |
| 2019 | -6.42 Million USD | 22.86% |
| 2018 | -8.66 Million USD | -26.01% |
| 2017 | -4.88 Million CAD | -177.36% |
| 2016 | -1.84 Million CAD | -1345.79% |
| 2015 | -127.75 Thousand USD | -0.88% |
| 2014 | -126.64 Thousand CAD | 16.67% |
| 2013 | -151.97 Thousand CAD | 29.23% |
| 2012 | -214.74 Thousand CAD | -37.97% |
| 2011 | -155.64 Thousand CAD | -0.48% |
| 2010 | -154.9 Thousand CAD | -5.74% |
| 2009 | -146.49 Thousand CAD | 38.72% |
| 2008 | -239.06 Thousand CAD | 60.25% |
| 2007 | -601.47 Thousand CAD | 12.4% |
| 2006 | -686.59 Thousand CAD | -88.09% |
| 2005 | -365.03 Thousand CAD | -58.59% |
| 2004 | -230.18 Thousand CAD | 59.39% |
| 2003 | -566.84 Thousand CAD | -158.09% |
| 2002 | -219.63 Thousand CAD | -158.0% |
| 2001 | -85.12 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q1 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2022 Q2 | -109.25 Thousand USD | 23.99% |
| 2022 Q4 | - USD | 100.0% |
| 2022 Q1 | -143.75 Thousand USD | 31.92% |
| 2022 Q3 | -109.99 Thousand USD | -0.67% |
| 2022 FY | - USD | 100.0% |
| 2021 Q2 | 116.66 Thousand USD | 136.42% |
| 2021 Q1 | -320.36 Thousand USD | -170.02% |
| 2021 Q3 | -179.67 Thousand USD | -254.01% |
| 2021 Q4 | -211.15 Thousand USD | -17.52% |
| 2021 FY | - USD | -582.3% |
| 2020 Q2 | -107.75 Thousand USD | 58.68% |
| 2020 Q3 | -176.08 Thousand USD | -63.4% |
| 2020 Q4 | 457.51 Thousand USD | 359.83% |
| 2020 FY | - USD | 98.25% |
| 2020 Q1 | -260.81 Thousand USD | 75.45% |
| 2019 FY | - USD | 22.86% |
| 2019 Q4 | -1.06 Million USD | -344.15% |
| 2019 Q3 | -239.15 Thousand USD | 85.37% |
| 2019 Q1 | -2.04 Million USD | 43.9% |
| 2019 Q2 | -1.63 Million USD | 20.03% |
| 2018 Q4 | -3.64 Million USD | -620.52% |
| 2018 Q3 | -505.64 Thousand CAD | 62.15% |
| 2018 Q2 | -1.33 Million CAD | -61.59% |
| 2018 Q1 | -826.7 Thousand CAD | 50.69% |
| 2018 FY | - USD | -26.01% |
| 2017 Q1 | -1.56 Million CAD | -1339.52% |
| 2017 Q3 | -800.3 Thousand CAD | 12.5% |
| 2017 Q4 | -1.67 Million CAD | -109.49% |
| 2017 FY | - CAD | -177.36% |
| 2017 Q2 | -914.66 Thousand CAD | 41.73% |
| 2016 FY | - CAD | -1345.79% |
| 2016 Q4 | -109.04 Thousand USD | 91.41% |
| 2016 Q3 | -1.26 Million USD | -2963.56% |
| 2016 Q1 | -33 Thousand USD | 2.14% |
| 2016 Q2 | -41.43 Thousand USD | -25.53% |
| 2015 Q3 | -41.17 Thousand CAD | -45.75% |
| 2015 Q4 | -33.73 Thousand USD | 18.07% |
| 2015 Q2 | -28.24 Thousand CAD | -5.08% |
| 2015 Q1 | -26.88 Thousand CAD | 11.02% |
| 2015 FY | - USD | -0.88% |
| 2014 Q2 | -39.45 Thousand CAD | -57.77% |
| 2014 Q3 | -33.95 Thousand CAD | 13.94% |
| 2014 Q4 | -30.21 Thousand CAD | 11.02% |
| 2014 FY | - CAD | 16.67% |
| 2014 Q1 | -25 Thousand CAD | 27.99% |
| 2013 Q2 | -44.69 Thousand CAD | -24.94% |
| 2013 FY | - CAD | 29.23% |
| 2013 Q4 | -34.72 Thousand CAD | 4.5% |
| 2013 Q3 | -36.36 Thousand CAD | 18.65% |
| 2013 Q1 | -35.77 Thousand CAD | 26.71% |
| 2012 FY | - CAD | -37.97% |
| 2012 Q3 | -57.04 Thousand CAD | 0.19% |
| 2012 Q4 | -48.81 Thousand CAD | 14.43% |
| 2012 Q1 | -37.8 Thousand CAD | 35.34% |
| 2012 Q2 | -57.15 Thousand CAD | -51.19% |
| 2011 Q1 | -46.29 Thousand CAD | -172.28% |
| 2011 Q2 | -24.32 Thousand CAD | 47.46% |
| 2011 Q3 | -31.12 Thousand CAD | -27.94% |
| 2011 FY | - CAD | -0.48% |
| 2011 Q4 | -58.46 Thousand CAD | -87.87% |
| 2010 Q4 | 64.04 Thousand CAD | 298.72% |
| 2010 Q3 | -32.23 Thousand CAD | 0.72% |
| 2010 FY | - CAD | -5.74% |
| 2010 Q2 | -32.46 Thousand CAD | 0.0% |
| 2009 FY | - CAD | 38.72% |
| 2008 Q3 | -3.57 Million CAD | -8773.21% |
| 2008 Q4 | 402.13 Thousand CAD | 111.24% |
| 2008 Q2 | -40.31 Thousand CAD | 23.76% |
| 2008 Q1 | -52.87 Thousand CAD | 72.61% |
| 2008 FY | - CAD | 60.25% |
| 2007 Q3 | -70.05 Thousand CAD | 73.9% |
| 2007 Q2 | -268.38 Thousand CAD | -315.12% |
| 2007 Q1 | -64.65 Thousand CAD | -68.2% |
| 2007 FY | - CAD | 12.4% |
| 2007 Q4 | -193.06 Thousand CAD | -175.58% |
| 2006 Q3 | -73.85 Thousand CAD | 5.02% |
| 2006 Q4 | -38.43 Thousand CAD | 47.95% |
| 2006 Q1 | -475.75 Thousand CAD | -294.18% |
| 2006 Q2 | -77.75 Thousand CAD | 83.66% |
| 2006 FY | - CAD | -88.09% |
| 2005 Q2 | -51.46 Thousand CAD | 36.14% |
| 2005 Q4 | -120.69 Thousand CAD | 35.23% |
| 2005 FY | - CAD | -58.59% |
| 2005 Q3 | -186.34 Thousand CAD | -262.09% |
| 2005 Q1 | -80.58 Thousand CAD | -13.91% |
| 2004 Q4 | -70.74 Thousand CAD | -65.69% |
| 2004 Q3 | -42.69 Thousand CAD | 6.76% |
| 2004 Q2 | -45.79 Thousand CAD | 30.33% |
| 2004 FY | - CAD | 59.39% |
| 2004 Q1 | -65.72 Thousand CAD | 84.43% |
| 2003 Q1 | -56.15 Thousand CAD | 53.88% |
| 2003 Q2 | -45.28 Thousand CAD | 19.35% |
| 2003 Q3 | -38.75 Thousand CAD | 14.43% |
| 2003 Q4 | -110.79 Thousand CAD | -989.06% |
| 2003 FY | - CAD | -158.09% |
| 2002 Q1 | -36.75 Thousand CAD | 0.0% |
| 2002 FY | - CAD | -158.0% |
| 2002 Q2 | -43.28 Thousand CAD | -17.75% |
| 2002 Q4 | -97.39 Thousand CAD | -176.92% |
| 2002 Q3 | -43.96 Thousand CAD | -1.57% |
| 2001 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| BioElectronics Corporation | -274.29 Thousand USD | 100.0% |
| IR-Med Inc. | -4.89 Million USD | 100.0% |
| Polarean Imaging plc | -11.19 Million USD | 100.0% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | 100.0% |
| Avitar, Inc. | -1.66 Million USD | 100.0% |
| AVITA Medical, Inc. | -39.56 Million USD | 100.0% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | 100.0% |
| Össur hf. | 137.38 Million USD | 100.0% |
| Zecotek Photonics Inc. | -3.44 Million USD | 100.0% |
| QHSLab, Inc. | -91.29 Thousand USD | 100.0% |
| Wellstar International, Inc. | -1.35 Million USD | 100.0% |
| Össur hf. | 137.38 Million USD | 100.0% |
| Bionovate Technologies Corp | - USD | NaN% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | 100.0% |
| Escalon Medical Corp. | -58.46 Thousand USD | 100.0% |
| Aurora Spine Corporation | -454.37 Thousand USD | 100.0% |
| BrainsWay Ltd. | -2.31 Million USD | 100.0% |
| Lattice Biologics Ltd. | - USD | NaN% |
| NewCardio, Inc. | -9.37 Million USD | 100.0% |
| Hamilton Thorne Ltd. | 5.52 Million USD | 100.0% |
| Vivos Inc. | -2.79 Million USD | 100.0% |
| MicroPort Scientific Corporation | -347.57 Million USD | 100.0% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | 100.0% |
| REMSleep Holdings, Inc. | -1.66 Million USD | 100.0% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | 100.0% |
| Nanomix Corporation | -8.13 Million USD | 100.0% |
| Theraclion SA | -2.05 Million USD | 100.0% |
| Lifeline Biotechnologies, Inc. | - USD | NaN% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | 100.0% |
| Positron Corporation | -1.45 Million USD | 100.0% |
| Rafina Innovations Inc. | - USD | NaN% |
| Electromedical Technologies, Inc. | -1.72 Million USD | 100.0% |
| Lombard Medical, Inc. | -28.06 Million USD | 100.0% |
| ALR Technologies Inc. | -6.4 Million USD | 100.0% |
| Stratec SE | 39.91 Million USD | 100.0% |
| Vycor Medical, Inc. | 100.94 Thousand USD | 100.0% |
| Heart Tronics, Inc. | -14.85 Million USD | 100.0% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | 100.0% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 100.0% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 100.0% |
| VMS Rehab Systems, Inc. | -68.55 USD | 100.0% |
| Guided Therapeutics, Inc. | -3.12 Million USD | 100.0% |
| Ingen Technologies, Inc. | -8639.00 USD | 100.0% |
| Odyssey Group International, Inc. | -2.13 Million USD | 100.0% |
| United American Healthcare Corporation | -59 Thousand USD | 100.0% |
| ECGI Holdings, Inc. | -2.99 Million USD | 100.0% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | 100.0% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | 100.0% |
| Urologix, Inc. | -6.34 Million USD | 100.0% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | 100.0% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | 100.0% |
| SS Innovations International, Inc. | -20.37 Million USD | 100.0% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | 100.0% |
| Smith & Nephew plc | 1 Billion USD | 100.0% |
| NIOX Group Plc | 11.07 Million USD | 100.0% |
| Fuse Medical, Inc. | 1.83 Million USD | 100.0% |
| Broncus Holding Corporation | -25.19 Million USD | 100.0% |
| Brain Scientific Inc. | -7.93 Million USD | 100.0% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 100.0% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | 100.0% |